Feature|Articles|November 11, 2023
- Pharmaceutical Executive: November 2023
- Volume 43
- Issue 11
Pharmaceutical Executive: November 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 2 years ago
2024 Pipeline Report: First-World Focusabout 2 years ago
Pharma Should Embrace the Single Sign-Onabout 2 years ago
22nd Annual Industry Audit: The Pharma Value Pictureabout 2 years ago
Changing the Paradigm in AI Implementationabout 2 years ago
Reading the Tea Leaves for Biotech As 2024 Approachesabout 2 years ago
Pharma Giving is Still Strong Despite Post-Pandemic Shiftsabout 2 years ago
Equity for Women in Healthcare: 131 Years is Too Long to Waitabout 2 years ago
A Peek at PotentialNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
FDA Announces Agency-Wide Deployment of Agentic AI Tools
4
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
5
